Compared to the control group, the concentration of serum tumor necrosis factor-α (TNF-α) (38, 39, 45) significantly decreased in the treatment group, but this had no significant correlation with the improvement in post-stroke function (Supplementary Figures S5; Table 1). Here, TNF is linked to stroke disorder.